Janus Henderson Group PLC Ac Immune Sa Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 30, 2019
SELL
$3.65 - $11.68 $5.76 Million - $18.4 Million
-1,578,814 Closed
0 $0
Q4 2018

Feb 06, 2019
SELL
$7.35 - $11.7 $656,818 - $1.05 Million
-89,363 Reduced 5.36%
1,578,814 $14.9 Million
Q3 2018

Nov 09, 2018
BUY
$7.88 - $16.45 $13.1 Million - $27.4 Million
1,668,177 New
1,668,177 $13.3 Million

Others Institutions Holding ACIU

# of Institutions
48
Shares Held
27.9M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $218M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email